
Seagen SGEN
Quarterly report 2023-Q3
added 05-16-2026
Seagen Total Inventories 2011-2026 | SGEN
Annual Total Inventories Seagen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 M | 201 M | 116 M | 85.9 M | 53.2 M | 60 M | 68.1 M | 57 M | 43.5 M | 27.1 M | 37.7 M | 9.47 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 9.47 M | 98.8 M |
Quarterly Total Inventories Seagen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 531 M | 487 M | 478 M | 427 M | 365 M | 319 M | 276 M | 201 M | 181 M | 163 M | 147 M | 116 M | 96.7 M | 90 M | 84.7 M | 85.9 M | 92 M | 73.2 M | 67.2 M | 53.2 M | 75.2 M | 70.9 M | 71.9 M | 60 M | 60.8 M | 69.2 M | 60.7 M | 68.1 M | 71.6 M | 71.7 M | 60 M | 57 M | 44.5 M | 47.5 M | 43.1 M | 43.5 M | 37.5 M | 30.5 M | 29 M | 27.1 M | 26 M | 27.1 M | 27.1 M | 37.7 M | 37.7 M | 25.7 M | 15.8 M | 9.47 M | 3.43 M | - | 9.47 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 531 M | 3.43 M | 113 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.38 | -3.17 % | $ 162 M | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.15 | 0.16 % | $ 655 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Eton Pharmaceuticals
ETON
|
15.4 M | $ 31.58 | 3.44 % | $ 850 M | ||
|
Exelixis
EXEL
|
21.7 M | $ 52.92 | -0.13 % | $ 14.4 B | ||
|
Anika Therapeutics
ANIK
|
18.8 M | $ 14.97 | 2.75 % | $ 215 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M |